Skip to main content
. 2018 Mar 12;51(1):119–127. doi: 10.4143/crt.2018.019

Table 2.

Best overall response

Confirmed best response Irinotecan plus cisplatin (n=173) Etoposide plus cisplatin (n=189) p-value
CR 2 (1.2) 3 (1.6) -
PR 106 (61.3) 88 (46.6) -
Stable disease 24 (13.9) 51 (27.0) -
Progressive disease 4 (2.3) 18 (9.5) -
Not evaluated 37 (21.4) 29 (15.3) -
Objective response rate (CR+PR) (%) 62.4 48.2 0.006a)

Values are presented as number (%) unless otherwise indicated. CR, complete response; PR, partial response.

a)

Chi-square test.